Greenwich Wealth Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95K | Hold |
10,050
| – | – | ﹤0.01% | 245 |
|
|
2025
Q1 | $54K | Buy |
+10,050
| New | +$54K | ﹤0.01% | 236 |
|
|
2024
Q4 | – | Sell |
-11,700
| Closed | -$93K | – | 260 |
|
|
2024
Q3 | $93K | Buy |
11,700
+900
| +8% | +$7.15K | 0.01% | 242 |
|
|
2024
Q2 | $94K | Buy |
+10,800
| New | +$94K | 0.01% | 232 |
|
|
2020
Q4 | – | Sell |
-3,180
| Closed | -$16K | – | 194 |
|
|
2020
Q3 | $16K | Buy |
3,180
+700
| +28% | +$3.52K | ﹤0.01% | 190 |
|
|
2020
Q2 | $19K | Buy |
2,480
+1,340
| +118% | +$10.3K | ﹤0.01% | 188 |
|
|
2020
Q1 | $12K | Buy |
+1,140
| New | +$12K | ﹤0.01% | 183 |
|